Status:
UNKNOWN
Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change
Lead Sponsor:
Royal Brisbane and Women's Hospital
Conditions:
Phlebitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to investigate the effects of extending the dwell time of peripheral intravenous cannulas on clinical outcomes and cost.
Detailed Description
Among hospitalized patients, intravenous therapy is the most common invasive procedure. It is associated with a phlebitis rate of between 1.1% and 63% and a central venous catheter related bacteremia ...
Eligibility Criteria
Inclusion
- Patients are eligible to join the Peripheral Venous Catheter Trial if:
- They are inpatients at the Royal Brisbane and Royal Women's Hospital who are at least 18 years of age
- AND
- They are scheduled or expected to have a peripheral venous catheter indwelling for at least 4 days.
- AND
- They have had their catheter inserted by a nurse from the IV Therapy Team
Exclusion
- Patients with an existing bloodstream infection
- Those receiving immunosuppressive treatment
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00103636
Start Date
March 1 2004
End Date
December 1 2004
Last Update
June 24 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brisbane and Women's Hospital
Brisbane, Queensland, Australia, 4029